Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia

Tumor‐induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by mesenchymal tumors that secrete fibroblast growth factor 23 (FGF23). Patients present with progressive bone pain, muscle weakness, and fragility fractures. TIO is characterized by hypophosphatemia, excess renal phosphate ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Jan de Beur, Suzanne M., Minisola, Salvatore, Xia, Wei‐bo, Abrahamsen, Bo, Body, Jean‐Jacques, Brandi, Maria Luisa, Clifton‐Bligh, Roderick, Collins, Michael, Florenzano, Pablo, Houillier, Pascal, Imanishi, Yasuo, Imel, Erik A., Khan, Aliya A., Zillikens, M. Carola, Fukumoto, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108006/
https://www.ncbi.nlm.nih.gov/pubmed/36511653
http://dx.doi.org/10.1111/joim.13593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108006/
https://www.ncbi.nlm.nih.gov/pubmed/36511653
http://dx.doi.org/10.1111/joim.13593

Ejemplares similares